Prognostic Values of Galectin-3 and the Macrophage Migration Inhibitory Factor (MIF) in Human Colorectal Cancers
- 1 May 2003
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 16 (5) , 491-504
- https://doi.org/10.1097/01.mp.0000068235.45178.c1
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Interleukin-6 Is an Autocrine Growth Factor in Human Prostate CancerThe American Journal of Pathology, 2001
- Detection of Macrophage Migration Inhibitory Factor (MIF) in Human Cholesteatomas and Functional Implications of Correlations to Recurrence Status and to Expression of Matrix Metalloproteinases‐3/9, Retinoic Acid Receptor‐β, and Anti‐apoptotic Galectin‐3The Laryngoscope, 2001
- Galectins Are Differentially Expressed in Supratentorial Pilocytic Astrocytomas, Astrocytomas, Anaplastic Astrocytomas and Glioblastomas, and Significantly Modulate Tumor Astrocyte MigrationBrain Pathology, 2001
- Colorectal cancer and metastasectomy: Adjuvant treatment in Dukes' B and C diseaseAnnals of Oncology, 2000
- Tumor ImmunologyImmunity, 1998
- Prognostic factors in colorectal cancerDiseases of the Colon & Rectum, 1998
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Malignant cell glycoproteins and glycolipidsCritical Reviews in Oncology/Hematology, 1989
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- The classification of cancer of the rectumThe Journal of Pathology and Bacteriology, 1932